-
1دورية أكاديمية
المؤلفون: Belkouz, A., Wilmink, J.W., Haj Mohammad, N., Hagendoorn, J., de Vos-Geelen, J., Dejong, C.H.C., Homs, M.Y.V., Groot Koerkamp, B., van Gulik, T.M., van Oijen, M.G.H., Punt, C.J.A., Klümpen, H. *
المصدر: In Critical Reviews in Oncology / Hematology July 2020 151
-
2
المؤلفون: Jong, E.J.M. de, Janssen, Q.P., Simons, T.F.A., Besselink, M.G., Bonsing, B.A., Bouwense, S.A.W., Geurts, S.M.E., Homs, M.Y.V., Meijer, V.E. de, Tjan-Heijnen, V.C.G., Laarhoven, H.W.M. van, Valkenburg-van Iersel, L.B.J., Wilmink, J.W., Geest, L.G. van der, Koerkamp, B.G., Vos-Geelen, J. de, Dutch Pancreatic Canc Grp
المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Heelkunde (9), MUMC+: MA Medische Oncologie (9), Medical Oncology, Surgery, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Oncology, Center for Liver, Digestive and Metabolic Diseases (CLDM), Groningen Institute for Organ Transplantation (GIOT), Internal medicine, VU University medical center
المصدر: the Dutch Pancreatic Cancer Group 2021, ' Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma ', International Journal of Cancer . https://doi.org/10.1002/ijc.33916
International Journal of Cancer, 150(10), 1654-1663. Wiley
International Journal of Cancer, 150(10), 1654-1663. WILEY
International Journal of Cancer, 150(10), 1654-1663. Wiley-Liss Inc.
International Journal of Cancer. Wiley-Liss Inc.مصطلحات موضوعية: Cancer Research, RESECTION, endocrine system diseases, pancreatic cancer, MULTICENTER, PHASE-III TRIAL, CHEMOTHERAPY, OPEN-LABEL, Deoxycytidine, Gemcitabine, CANCER, THERAPY, TRENDS, Pancreatic Neoplasms, FOLFIRINOX, Oncology, SDG 3 - Good Health and Well-being, Chemotherapy, Adjuvant, Antineoplastic Combined Chemotherapy Protocols, SURVIVAL, Humans, Capecitabine, Carcinoma, Pancreatic Ductal
وصف الملف: application/pdf
-
3
المؤلفون: Versteijne, E., Dam, J.L. van, Suker, M., Janssen, Q.P., Groothuis, K., Akkermans-Vogelaar, J.M., Besselink, M.G., Bonsing, B.A., Buijsen, J., Busch, O.R., Creemers, G.J.M., Dam, R.M. van, Eskens, F.A.L.M., Festen, S., Groot, J.W.B. de, Koerkamp, B.G., Hingh, I.H. de, Homs, M.Y.V., Hooft, J.E. van, Kerver, E.D., Luelmo, S.A.C., Neelis, K.J., Nuyttens, J., Paardekooper, G.M.R.M., Patijn, G.A., Sangen, M.J.C. van der, Vos-Geelen, J. de, Wilmink, J.W., Zwinderman, A.H., Punt, C.J., Tienhoven, G. van, Eijck, C.H.J. van, Dutch Pancreatic Canc Grp
المساهمون: Surgery, Medical Oncology, Radiotherapy, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Gastroenterology and Hepatology, Oncology, Epidemiology and Data Science, APH - Methodology, Radiation Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie, MUMC+: MA Heelkunde (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)
المصدر: Journal of Clinical Oncology, 40(11), 1220-1230. American Society of Clinical Oncology
Versteijne, E, van Dam, J L, Suker, M, Janssen, Q P, Groothuis, K, Akkermans-Vogelaar, J M, Besselink, M G, Bonsing, B A, Buijsen, J, Busch, O R, Creemers, G-J M, van Dam, R M, Eskens, F A L M, Festen, S, de Groot, J W B, Groot Koerkamp, B, de Hingh, I H, Homs, M Y V, van Hooft, J E, Kerver, E D, Luelmo, S A C, Neelis, K J, Nuyttens, J, Paardekooper, G M R M, Patijn, G A, van der Sangen, M J C, de Vos-Geelen, J, Wilmink, J W, Zwinderman, A H, Punt, C J, van Tienhoven, G & van Eijck, C H J 2022, ' Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer : Long-Term Results of the Dutch Randomized PREOPANC Trial ', Journal of Clinical Oncology, vol. 40, no. 11, pp. 1220-1230 . https://doi.org/10.1200/JCO.21.02233
Journal of Clinical Oncology, 40(11), 1220-+. LIPPINCOTT WILLIAMS & WILKINS
Journal of clinical oncology, 40(11), 1220-1230. American Society of Clinical Oncologyمصطلحات موضوعية: Cancer Research, MULTICENTER, ADENOCARCINOMA, Chemoradiotherapy, OPEN-LABEL, THERAPY, TRENDS, Neoadjuvant Therapy, Pancreatic Neoplasms, Survival Rate, CHEMORADIATION, ADJUVANT CHEMOTHERAPY, Oncology, GEMCITABINE, SDG 3 - Good Health and Well-being, Antineoplastic Combined Chemotherapy Protocols, Humans
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0c80077a065c4bb8306a86eb726545e
http://www.scopus.com/inward/record.url?scp=85125798289&partnerID=8YFLogxK -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5
المؤلفون: Sijde, F. van der, Dik, W.A., Mustafa, D.A.M., Vietsch, E.E., Besselink, M.G., Debets, R., Koerkamp, B.G., Haberkorn, B.C.M., Homs, M.Y.V., Janssen, Q.P., Luelmo, S.A.C., Mekenkamp, L.J.M., Oostvogels, A.A.M., Nijenhuis, M.A.W.S.T., Wilmink, J.W., Eijck, C.H.J. van
المساهمون: Surgery, Immunology, Pathology, Medical Oncology, CCA - Cancer Treatment and Quality of Life, Amsterdam Gastroenterology Endocrinology Metabolism, Oncology, CCA - Cancer biology and immunology
المصدر: Frontiers in Immunology, 13:898498. Frontiers Media S.A.
Frontiers in immunology, 13:898498. Frontiers Media S.A.
Frontiers in Immunology, 13. FRONTIERS MEDIA SAمصطلحات موضوعية: Interleukin-7, pancreatic cancer, Immunology, Interleukin-18, Leucovorin, treatment response, Irinotecan, Oxaliplatin, Pancreatic Neoplasms, Interleukin 1 Receptor Antagonist Protein, IL-1RA, SDG 3 - Good Health and Well-being, Antineoplastic Combined Chemotherapy Protocols, cytokine, Cytokines, Humans, biomarker, Immunology and Allergy, Fluorouracil, Chemokine CCL4, Carcinoma, Pancreatic Ductal
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::493dbacff71760bbb74091a085213bbc
https://doi.org/10.3389/fimmu.2022.898498 -
6
المؤلفون: Lau, S.P., Land, F.R. van 't, Burg, S.H. van der, Homs, M.Y.V., Lolkema, M.P., Aerts, J.G.J.V., Eijck, C.H.J. van
المساهمون: Surgery, Pulmonary Medicine, Medical Oncology
المصدر: BMJ Open, 12(6):e060431. BMJ Publishing Group
BMJ Open, 12(6). BMJ PUBLISHING GROUPمصطلحات موضوعية: Adult, Vaccines, Clinical Trials, Phase I as Topic, Pancreatic cancer, General Medicine, Dendritic Cells, Dendritic Cell, Cancer Vaccines, Pancreatic Neoplasms, SDG 3 - Good Health and Well-being, Antineoplastic Combined Chemotherapy Protocols, CD40, Humans, Immunotherapy
وصف الملف: application/pdf
-
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8
المؤلفون: Jeene, P.M., Vermeulen, B.D., Rozema, T., Braam, P.M., Lips, I., Muller, K., Kampen, D. van, Homs, M.Y.V., Oppedijk, V., Berbee, M., Rossum, P.S.N. van, Sharouni, S. el, Siersema, P.D., Hulshof, M.C.C.M., POLDER Study Grp
المساهمون: Graduate School, Radiotherapy, CCA - Cancer Treatment and Quality of Life, Radiotherapie, MUMC+: MA Radiotherapie OC (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Medical Oncology
المصدر: Journal of thoracic oncology, 15(8), 1361-1368. International Association for the Study of Lung Cancer
Journal of Thoracic Oncology, 15, 1361-1368
Journal of Thoracic Oncology, 15(8), 1361-1368. Elsevier Science
Journal of Thoracic Oncology, 15(8), 1361-1368. ELSEVIER SCIENCE INC
Journal of Thoracic Oncology, 15, 8, pp. 1361-1368
Journal of Thoracic Oncology, 15(8), 1361-1368. International Association for the Study of Lung Cancerمصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, Esophageal Neoplasms, CARCINOMA, medicine.medical_treatment, Brachytherapy, Esophageal cancer, External beam radiotherapy, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, SDG 3 - Good Health and Well-being, medicine, MANAGEMENT, Humans, Prospective Studies, Prospective cohort study, business.industry, FRACTIONATION, SINGLE-DOSE BRACHYTHERAPY, Stent, Dysphagia, medicine.disease, Radiation therapy, Palliation, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cohort, Radiology, medicine.symptom, business, Deglutition Disorders
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7b5e9cb46fc7a70cf133fad9f29e020
https://cris.maastrichtuniversity.nl/en/publications/94163e4c-5333-4994-affe-37a28ad4e395 -
9
المؤلفون: Versteijne, E., Suker, M., Groothuis, K., Akkermans-Vogelaar, J.M., Besselink, M.G., Bonsing, B.A., Buijsen, J., Busch, O.R., Creemers, G.J.M., Dam, R.M. van, Eskens, F.A.L.M., Festen, S., Groot, J.W.B. de, Koerkamp, B.G., Hingh, I.H. de, Homs, M.Y.V., Hooft, J.E. van, Kerver, E.D., Luelmo, S.A.C., Neelis, K.J., Nuyttens, J., Paardekooper, G.M.R.M., Patijn, G.A., Sangen, M.J.C. van der, Vos-Geelen, J. de, Wilmink, J.W., Zwinderman, A.H., Punt, C.J., Eijck, C.H. van, Tienhoven, G. van, Dutch Pancreatic Canc Grp
المساهمون: Graduate School, Radiotherapy, CCA - Cancer Treatment and Quality of Life, Surgery, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Gastroenterology and Hepatology, Oncology, Epidemiology and Data Science, APH - Methodology, Radiotherapie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Medical Oncology
المصدر: Journal of Clinical Oncology, 38(16), 1763-1773. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 38(16), 1763-1773. American Society of Clinical Oncology
Journal of Clinical Oncology, 38(16), 1763-1773. American Society of Clinical Oncology
J Clin Oncolمصطلحات موضوعية: Cancer Research, medicine.medical_specialty, FOLFIRINOX, MULTICENTER, DUCTAL ADENOCARCINOMA, THERAPY, law.invention, 03 medical and health sciences, 0302 clinical medicine, ADJUVANT CHEMOTHERAPY, SDG 3 - Good Health and Well-being, Randomized controlled trial, Borderline resectable, law, FULL-DOSE GEMCITABINE, NEOADJUVANT CHEMORADIATION, Pancreatic cancer, medicine, Carcinoma, Humans, business.industry, Dose fractionation, ORIGINAL REPORTS, Chemoradiotherapy, CONCURRENT RADIATION, medicine.disease, OPEN-LABEL, Neoadjuvant Therapy, Surgery, Pancreatic Neoplasms, Clinical trial, Oncology, 030220 oncology & carcinogenesis, SURVIVAL, 030211 gastroenterology & hepatology, business
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28808dd04ae7ac931715c0e523a5f9c5
https://doi.org/10.1200/jco.19.02274 -
10
المؤلفون: Mackay, T.M., Smits, F.J., Roos, D., Bonsing, B.A., Bosscha, K., Busch, O.R., Creemers, G.J., Dam, R.M. van, Eijck, C.H.J. van, Gerhards, M.F., Groot, J.W.B. de, Koerkamp, B.G., Mohammad, N.H., Harst, E. van der, Hingh, I.H.J.T. de, Homs, M.Y.V., Kazemier, G., Liem, M.S.L., Meijer, V.E. de, Molenaar, I.Q., Nieuwenhuijs, V.B., Santvoort, H.C. van, Schelling, G.P. van der, Stommel, M.W.J., Tije, A.J. ten, Vos-Geelen, J. de, Wit, F., Wilmink, J.W., Laarhoven, H.W.M. van, Besselink, M.G., Dutch Pancreatic Canc Grp
المساهمون: Graduate School, AGEM - Digestive immunity, AGEM - Endocrinology, metabolism and nutrition, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and Quality of Life, Surgery, Oncology, CCA - Cancer Treatment and quality of life, Medical Oncology, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
المصدر: HPB: The official journal of the International Hepato Pancreato Biliary Association, 22(2), 233-240. John Wiley and Sons Inc.
Hpb, 22, 2, pp. 233-240
International Hepato-Pancreato Biliary Association., 22(2), 233. John Wiley and Sons Inc.
HPB, 22(2), 233-240. ELSEVIER SCI LTD
HPB, 22(2), 233-240. John Wiley and Sons Inc.
HPB, 22(2), 233-240. John Wiley & Sons Inc.
Hpb, 22(2), 233-240. ELSEVIER SCI LTD
Mackay, T M, Smits, F J, Roos, D, Bonsing, B A, Bosscha, K, Busch, O R, Creemers, G-J, van Dam, R M, van Eijck, C H J, Gerhards, M F, de Groot, J W B, Groot Koerkamp, B, Haj Mohammad, N, van der Harst, E, de Hingh, I H J T, Homs, M Y V, Kazemier, G, Liem, M S L, de Meijer, V E, Molenaar, I Q, Nieuwenhuijs, V B, van Santvoort, H C, van der Schelling, G P, Stommel, M W J, ten Tije, A J, de Vos-Geelen, J, Wit, F, Wilmink, J W, van Laarhoven, H W M, Besselink, M G & Dutch Pancreatic Cancer Group 2020, ' The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis ', HPB, vol. 22, no. 2, pp. 233-240 . https://doi.org/10.1016/j.hpb.2019.06.019
Hpb, 22, 233-240مصطلحات موضوعية: Male, SURGERY, medicine.medical_treatment, INTERNATIONAL STUDY-GROUP, 030230 surgery, SURGICAL COMPLICATIONS, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Risk Factors, Odds Ratio, Hospital Mortality, POSTOPERATIVE COMPLICATIONS, Netherlands, Gastroenterology, Age Factors, Middle Aged, Pancreaticoduodenectomy, OPEN-LABEL, CANCER, Pancreatic fistula, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, PANCREATICODUODENECTOMY, Female, medicine.drug, Carcinoma, Pancreatic Ductal, medicine.medical_specialty, Hospitals, Low-Volume, 03 medical and health sciences, Pancreatectomy, Pancreatic cancer, medicine, Journal Article, Humans, Aged, Retrospective Studies, Chemotherapy, Performance status, Hepatology, business.industry, MORTALITY, Postoperative complication, Odds ratio, medicine.disease, Gemcitabine, Surgery, Pancreatic Neoplasms, Logistic Models, DEFINITION, GEMCITABINE, Neoplasm Grading, business
وصف الملف: text/plain; application/pdf